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A Schiff base has been prepared by the reaction of 4-acetyl-5-methyl-2-(4-methylphenyl)-2,4-dihydro-3H-pyrazole-3-
one with different substituted amines. Treatment of this Schiff base with chlorobactyl chloride affords the corresponding 
azetidinone in good yield. All the new compounds have been characterized by IR, 1H NMR, GC-MS and elemental analysis. 
The antibacterial activity of these compounds has been determined with the reference of standard drug. 
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The synthesis of heterocyclic compound has always 
drawn the attention of chemist over the years mainly. 
Because of their important biological activities
1
. 
Pyrazolones is a five-member heterocyclic compound 
containing one ketonic group and two nitrogen atoms 
adjacent to each other. Pyrazolone derivatives play an 
important role in heterocyclic compound history and 
possess considerable biological activities, thus making it 
an important pharmacophore for carrying out further 
drug research
2
. One such heterocyclic, 2-azetidinone, a 
very well-known compound for the medicinal 
chemistry, since it forms a part of antibiotic molecules
3
. 
They are carbonyl derivatives of azetidinone containing 
carbonyl group at position- 2. These are known as 2- 
azetidinone
4
. The 2- azetidinone ring system, a common 
structural features of a number of wide spectrum β-
lactam antibiotics, including penicinils, cephalosporin, 
carbapenems, nocardiacins and monobactams, which 
have been widely use as chemotherapic agent to treat 
bacterial infections and microbial diseases
5
. The utility 
of azetidinone as synthon for various biological active 



















. They also function as enzyme inhibitors
14
 
and are effective on the CNS
15
. Cycloaddition of 
monochloroacetylchloride with imines (Schiff base) 
result in formation of 2- azetidinone(β-lactam). The 
reaction involves direct acylation of Schiff base with 
monochloroacetylchloride. The reaction is carried out 
with base as triethylamine gives β- lactam. 
Result and Discussion 
Chemistry
Azetidinone derivatives III1-5 were prepared using 
the method summarized in Scheme I. First, 3-methyl-
1-(4-methylphenyl)-2-pyrazolineon acylation gives 4-
acetyl-5-methyl-2-(4-methyl- phenyl)-2,4-dihydro-
3H-pyrazole-3-one derivatives I(1-5). Compounds 
I(1-5) on reaction with substituted amines afforded 
Schiff base derivatives II(1-5). Finally the Schiff 
bases upon reaction with chloroacetyl chloride in the 
presence of triethylamine afforded azetidinone 
derivatives III(1-5). 
The structure of compounds was assigned on the 
basis of spectral data. In the IR spectra of azetidinone 
derivatives the carbonyl group of the β-lactam ring 
appeared as a characteristic absorption band in the IR 
range 1660-1675 cm
–1
.The IR absorption bands and 
1H NMR signal characteristic of azomethine group 
disappeared from the spectra of azetidinone 
derivatives which conforms that the cyclization 
reaction with chloroacetyl chloride took place. The 
1H NMR spectra of III(1-5) showed signals, which 
are characteristic for CH-Cl that appears in the range 
of 5.2-5.9. Synthetic route is given as below. 
Experimental Section 
Melting points were recorded in open capillary 
tube and are uncorrected. The IR spectra were 
recorded on a Perkin–Elmer 37 spectrophotometer 
and 
1
H NMR spectra were recorded in DMSO-d6 with
TMS as internal standard on Bruker AM 400 




instrument (at 400 MHz). Mass spectra were recorded 
on MS route JMS 600-H. All the synthesized 
compounds were purified by recrystalization. All the 
chemicals and solvents were AR grade and were used 




Step-1: Synthesis of 4-acetyl-5-methyl-2-(4-
methylphenyl)-2, 4-dihydro-3H-pyrazole-3-one 
3-Methyl-1-(4-methylphenyl)-2-pyrazoline-one in 
solution of dioxane and acetyl chloride was refluxed 
for 2h in oil bath with calcium hydroxide and cooled 
to RT. The resulting reaction mass is added to dil. 
HCL, the crude product (I1-5) was collected by 
filtration and washed several time with water and then 
dried in air. 
 
Step- 2: Synthesis of Schiff base 
4-Acetyl-5-methyl-2-(4-methylphenyl)-2, 4-dihydro-
3H-pyrazole-3-one (0.01mol) is treated with 
substituted amine in ethanol reflux for 3-5 h. Then 
mixture is cooled. Solid yellow product (II1-5) 
filtered and washed with methanol or ethanol. 
 
Step-3: Synthesis of 2-azetidinone derivatives 
Schiff bases obtained in step-2 (0.01mol) in DMF 
on further treatment with base triethylamine 
(0.01 mol) and acylated with chloroacetyl chloride 
(0.01mol) as cyclic agent. The reaction mixture was 
stirred for 5-7 hrs. The product (III1-5) was isolated 




m.p.141-143°C (uncorrected). Yield: 65%. IR: 2893 
Aromatic C-H stretching, 1669 C=O, 1605, C=N, 1537, 




H NMR: δ 6.98-7.63 (8H, m, 
Ar-H), 3.1 (1H, s, Pyrazolone), 5.04 (1H, s, CH), 1.96 
(3H, s, CH3), 2.34 (3H, s, CH3), 1.56 (3H, s, CH3). Anal. 
Calcd for C20H20ClN3O2: C, 66.05; H, 5.28; N, 11.0. 












m.p.156-157°C (uncorrected). Yield: 68%. IR: 
2896 Aromatic C-H stretching, 1665 C=O, 1602, 




H NMR: δ 7.0-
8.09 (8H, m, Ar-H), 3.0 (1H, s, Pyrazolone), 5.04 (1H, 
s, CH), 1.93 (3H, s, CH3), 2.33 (3H, s, CH3), 1.53 (3H, 
s, CH3). Anal. Calcd for C20H19Cl2N3O2: C, 60.57; H, 





m.p.147-148°C (uncorrected). Yield: 67%. IR: 
2899 Aromatic C-H stretching, 1668 C=O, 1609, 




H NMR: δ 7.0-
8.09 (8H, m, Ar-H), 3.1 (1H, s, Pyrazolone), 5.06 (1H, s, 
CH), 1.93 (3H, s, CH3), 2.34 (3H, s, CH3), 1.52 (3H, s, 
CH3). Anal. Calcd for C20H19Cl2N3O2: C, 60.59; H, 





m.p.154-155°C (uncorrected). Yield: 70%; IR: 
2896 Aromatic C-H stretching, 1662 C=O, 1610, 




H NMR: δ 
6.99-7.86 (8H, m, Ar-H), 3.04 (1H, s, Pyrazolone), 5.02 
(1H, s, CH), 1.96 (3H, s, CH3), 2.33 (3H, s, CH3), 1.52 
(3H, s, CH3). Anal. Calcd for C22H22ClN3O2: C, 66.75; 






m.p.154-155°C (uncorrected). Yield: 70%. IR: 
2902 Aromatic C-H stretching, 1670 C=O, 1608, 




H NMR: δ 7.0-
8.86 (8H, m, Ar-H), 3.2 (1H, s, Pyrazolone), 5.09 (1H, 
s, CH), 1.96 (3H, s, CH3), 2.35 (3H, s, CH3), 1.55 (3H, 
s, CH3). Anal. Calcd for C21H19ClN4O4: C, 59.09; H, 





We have used the Agar cup Method to evaluate the 
antibacterial activity. It is one of the non automated 
in vitro bacterial susceptibility tests. This classic 
method yields a zone of inhibition in mm result for 
the amount of antimicrobial agents that is needed to 
inhibit growth of specific microorganisms (Figure 1). 
It is carried out in Petri plates. Antibacterial activity 
of compounds is shown in Table I. 
 
Antifungal activity 
Antifungal activity of compounds (III 1-5) is 
shown in Table II and Figure 2. 
 
 




Figure 2 — Graphical representation of antifungal activity 
 
Table I — Antibactarial activity of compounds III1-5 
Compd Zone of Inhibition 
Gram Positive Gram Negative 
III1 17 16 19 15 
III2 09 07 08 10 
III3 17 17 15 16 
III4 10 07 09 06 
III5 08 10 09 11 
Chloroamphinocol 20 20 23 19 
 
Table II — Antifungal activity of compounds III1-5 
Compd Zone of Inhibition (in mm) 
C. albicans A. niger 
III1 08 07 
III2 17 21 
III3 17 20 
III4 19 19 
III5 19 20 
Greseofulvin 27 29 




Compounds III 1-5 showed moderate to good 
antimicrobial activity against standard drugs. 
 
Conclusion 
In this study new 2-azetidionone derivatives have 
been synthesize from Schiff Bases. The structures of 
all new compounds were proved using spectral 
methods. The compounds were evaluated for their 
antimicrobial. Antimicrobial potential of all 
compounds was reduced. 
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